StockLearn from Clustermicro · Stock Breakout ScannerStockLearn

Gaudium Ivf And Women Health Limited (GAUDIUMIVF)

Hospitals & Diagnostics · NSE · end-of-day 2026-10-19

₹97.58

Day change

-3.82%

1-year

+21.6%

From 52-week high

-38.3%

Weinstein stage

—

Minervini template

—

Gaudium Ivf And Women Health Limited closed at ₹97.58 on 2026-10-19, up 22% over the past year, 38% below its 52-week high. Over the year its annualised volatility was about 62%, with a largest fall of 38% from a peak.

About Gaudium Ivf And Women Health Limited

Gaudium IVF & Women Health Limited provides fertility treatment, IVF, women's healthcare, and related reproductive-health services. Rising awareness of fertility treatments and increasing demand for organized healthcare provide long-term growth opportunities. Expansion of clinics, medical capabilities, and geographic reach can increase patient access. Healthcare technology and specialized medical expertise can support differentiation. Treatment success rates, regulatory requirements, doctor availability, patient acquisition costs, and competition remain important considerations.

Price, RSI and MACD

6M1Y

Price · +1.7% over the period

RSI (14) · 31.1

MACD (12, 26, 9) · histogram -0.61

Price · +21.6% over the period

RSI (14) · 31.1

MACD (12, 26, 9) · histogram -0.61

Price: daily close adjusted for splits and bonuses, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.

Fundamentals

Market cap	Sales (TTM)	Net profit (TTM)	P/E	EPS (TTM)	P/B	ROE	Debt / equity	Free cash flow	EV / EBITDA	Beta
₹710 cr	—	—	27.7	3.67	4.66	15.0%	0.15	₹5 cr	19.7	—

Quarterly results

Quarter	Sales ₹ cr	Net profit ₹ cr	EPS	EPS YoY	Sales YoY	Net margin
Jun 2026	19	2	0.25	—	—	9.2%
Mar 2026	30	8	1.34	—	—	27.5%
Dec 2025	24	4	0.59	—	—	14.8%

Consolidated · EPS restated onto today's share count after splits and bonuses · net profit as filed.

Minervini SEPA — earnings checks 0 of 0 pass

Check	Result
Latest quarter EPS up 25%+ on a year ago	— Not assessable
EPS growth accelerating over 3 quarters	— Not assessable
Sales up 25%+, or sales growth accelerating	— Not assessable
Annual EPS up 25%+ in each of the last 2 years	— Not assessable
Net margin above the same quarter last year	— Not assessable

Investor methods

Method	Checks	Score	Verdict
Turtle	✗ Close above the prior 55-session high · 140.14 ✗ Close above the prior 20-session high · 123.00 ✓ Close below the prior 20-session low · 101.00 Donchian channel breakout - the Turtle traders' entry.		Breakdown
Graham	✗ Price at or below the Graham number · Graham number 41.58 ✗ P/E 15 or less · P/E 26.6 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 4.66 ✗ Current ratio 2 or more · 1.90 — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests.	43/100	Expensive

Each method's own rules applied to this stock - information, not a buy or sell signal. All were tested on 2024-26 data; only the Minervini trend template showed a consistent edge.

Hospitals & Diagnostics sector — top 10 by 1-year return

Stock	1M %	3M %	6M %	1Y %	3Y %	5Y %	P/E	P/B	ROE %	ROCE %	ROA %	D/E	EV/EBITDA	₹ Cr	Sales TTM ₹ Cr	Profit TTM ₹ Cr	EPS	Beta
GAUDIUMIVF this stock	-16.0	-34.1	+1.7	—	—	—	27.7	4.66	15.0	—	—	0.15	19.7	710	—	—	3.7	—
SAKAR	-21.8	+2.7	+51.5	+162.7	+158.4	+464.3	57.0	6.33	10.0	12.9	—	0.17	30.8	2,054	272	36	16.2	0.69
KOVAI	-5.6	-0.9	+7.0	+128.0	+118.8	+256.0	25.5	4.87	19.4	—	—	—	—	6,429	—	—	234.2	—
AHCL	+17.8	+79.8	+86.2	+112.4	—	—	11.1	6.23	47.4	—	—	0.19	30.7	1,434	—	—	2.4	0.44
VIJAYA	-12.2	+2.5	+33.7	+37.9	+134.0	+143.8	75.1	14.71	19.7	30.3	—	0.00	39.6	14,078	857	188	18.2	0.54
ENTERO	-13.2	+26.4	+18.2	+35.9	—	—	52.2	3.88	6.7	10.7	—	0.34	26.4	6,545	7,128	168	28.8	0.36
AMANTA	-13.3	-0.0	+21.9	+34.8	—	—	39.6	2.57	—	—	—	1.06	—	—	291	15	4.2	0.73
YATHARTH	-14.8	+14.4	+30.6	+19.8	+147.7	—	51.6	5.18	10.0	12.4	—	0.14	30.2	9,356	1,334	174	18.8	0.88
LALPATHLAB	-2.8	+8.9	+30.0	+18.6	+47.0	-0.3	56.8	12.32	21.6	29.1	—	0.00	36.2	30,900	2,891	546	32.5	0.41
THYROCARE	-15.3	-15.2	+19.9	+13.6	+151.4	+22.7	42.6	12.80	28.8	37.8	—	0.00	28.2	7,497	876	176	11.1	0.47
STARHEALTH	-0.9	-6.7	+7.0	+7.6	-8.9	—	35.7	3.15	8.9	—	—	—	—	31,904	—	—	15.3	0.41

A blank in a return column means the stock is younger than that window. P/B and ROE come from each company's own filings where held.

Hospitals & Diagnostics stocks of a similar size

Mastertr Bajaj Healthcare Limited Gpt Healthcare Limited Shalby Limited Ttk Healthcare Limited Anlon Healthcare Limited Suraksha Diagnostic Limited Jupiter Life Line Hospitals Limited

The live scanner - every stock ranked, filtered by method, stage and sector, with interactive charts - is in the StockLearn app. Open the StockLearn scanner →

Prices as of 2026-10-19, end of day, from NSE. Fundamentals from each company's own exchange filings (XBRL), EPS restated for splits and bonuses. Figures may be delayed and are for information only.

For research & education only — not investment advice. The methods, checks and verdicts are automated rules applied to public data, not buy/sell recommendations. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by the NSE or any exchange. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.

Terms · Privacy · Disclaimer · Refund · Contact